Aug 25, 2020 by Brian Orelli, PhDAstraZeneca Starts Clinical Trial Testing Its COVID-19 Treatment Antibody CocktailThe U.K.-based drugmaker is hedges its bets with AZD7442.
Aug 24, 2020 by Brian Orelli, PhDNovavax Starts Phase 2 Coronavirus Vaccine Clinical TrialThe biotech moves one step closer to hopefully launching NVX-CoV2373.
Aug 24, 2020 by Brian Orelli, PhDFDA Authorizes Plasma Antibodies as a COVID-19 TreatmentThe authorization is light on the data.
Aug 21, 2020 by Brian Orelli, PhDPfizer and BioNTech's Coronavirus Vaccine Candidate Produces Antibodies in People Up to 85 Years OldAny vaccine designed to prevent COVID-19 will need to do well at protecting older people.
Aug 19, 2020 by Brian Orelli, PhDHere's Why BioMarin Pharmaceutical Plummeted TodayThe biotech is going to have to wait awhile to get its hemophilia A treatment approved by the FDA.
Aug 14, 2020 by Brian Orelli, PhDHere's Why Evolent Health Dropped 10% on FridayA refinancing gone wrong?
Aug 14, 2020 by Brian Orelli, PhDCoronavirus Vaccine Will Be Free for Americans, Says HHS OfficialThe federal government will foot the bill for vaccines, while insurers and the CARES Act will cover the cost of administering them.
Aug 13, 2020 by Brian Orelli, PhDHere's Why BioCryst Pharmaceuticals Jumped Higher TodayThe company's new CFO made a substantial investment in the company. Should you follow suit?
Aug 11, 2020 by Brian Orelli, PhDBioNTech and Pfizer Hope to Have Late-Stage Coronavirus Vaccine Results by OctoberIt's a tight schedule, but it could mean the duo gains regulatory approval first.
Aug 11, 2020 by Brian Orelli, PhDNovavax Ready to Produce Nearly 3 Billion Coronavirus Vaccine Doses (With a Little Help From Friends)Government backing has helped the tiny biotech ramp up quickly.
Aug 10, 2020 by Brian Orelli, PhDHere's Why Momenta Pharmaceuticals Dropped 13.5% TodayNo news is apparently bad news.
Aug 8, 2020 by Brian Orelli, PhDNovavax Partners With Takeda to Sell Its Coronavirus Vaccine in JapanGlobal expansion is here for the vaccine that's months away from a regulatory approval.
Aug 7, 2020 by Brian Orelli, PhDHere's Why Arbutus Biopharma Fell TodayShort-term investors appear impatient.
Aug 6, 2020 by Brian Orelli, PhDGW Pharmaceuticals Drops After Hours Despite 72% Growth of Marijuana-Derived EpidiolexThe biotech's revenue growth is slowing.
Aug 5, 2020 by Brian Orelli, PhDHow Moderna Went From Coronavirus Sequence to a Phase-1-Ready Vaccine Candidate in 42 DaysThe biotech got a little help from Amazon's AWS.
Aug 5, 2020 by Brian Orelli, PhDInvitae Posts a Loss After a Revenue Decline in the Second QuarterNot all of the genetic tests it sells were particularly in demand as the COVID-19 pandemic intensified.
Aug 4, 2020 by Brian Orelli, PhDNovavax's Coronavirus Vaccine Induced Antibodies in 100% of Phase 1 Trial ParticipantsWhether the vaccine protects against COVID-19 remains to be seen.
Jul 31, 2020 by Brian Orelli, PhDSanofi and GlaxoSmithKline Snag a $2.1 Billion Contract for Their Coronavirus VaccineThe U.S. government is supporting development and manufacturing of the coronavirus vaccine in exchange for 100 million doses.
Jul 31, 2020 by Brian Orelli, PhDHere's Why Emergent BioSolutions Stock Jumped TodayThe expert in bioterrorism and emerging infectious diseases had a great second quarter, with more to come.
Jul 31, 2020 by Brian Orelli, PhDOPKO Health Grows Revenue by 33% on the Back of Its COVID-19 TestsThe company turned a profit during the second quarter.
